|
2024
|
Invention
|
Lyme disease vaccines comprising an adjuvant and borrelia outer surface protein a and c antigens.... |
|
|
Invention
|
Lyme disease vaccines comprising an adjuvant and a borrelia outer surface protein a antigen. Borr... |
|
|
Invention
|
Alkyl chain modified imidazoquinoline tlr7/8 agonist compounds and uses thereof.
Disclosed are a... |
|
2023
|
Invention
|
Toll-like receptor antagonist compounds and methods of use. The invention relates to compounds of... |
|
|
Invention
|
Immunogenic compositions against the omicron variant of severe acute respiratory syndrome coronav... |
|
|
Invention
|
Immunogenicity of a cpg-adjuvanted recombinant plague vaccine. Y. pestis in a subject in need the... |
|
|
G/S
|
Providing medical and other health information to medical professionals in the fields of medicine... |
|
|
G/S
|
Vaccines; pharmaceutical preparations for the prevention and treatment of infectious diseases and... |
|
|
G/S
|
Providing medical and other information to medical professionals in the fields of medicine, healt... |
|
|
G/S
|
Vaccines; pharmaceutical preparations for the prevention of
infectious diseases and chronic vira... |
|
|
Invention
|
Immunogenic compositions comprising a recombinant neuraminidase and cpg oligonucleotide adjuvant,... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment
of hepatitis, chronic viral infecti... |
|
|
G/S
|
Providing medical and other information to medical
professionals in the fields of medicine, heal... |
|
2022
|
Invention
|
Immunogenicity of a cpg-adjuvanted herpes zoster vaccine.
The present disclosure relates to meth... |
|
|
Invention
|
Immunogenicity of a cpg-adjuvanted herpes zoster vaccine. The present disclosure relates to metho... |
|
|
G/S
|
Pharmaceutical preparations for the prevention and treatment of hepatitis, chronic viral infectio... |
|
|
G/S
|
Medical, scientific, pharmaceutical, and biological research and product development consultation... |
|
2021
|
Invention
|
Method for quantifying cpg-containing oligonucleotides in compositions comprising alum.
The pres... |
|
|
Invention
|
Method for quantifying cpg-containing oligonucleotides in formulations comprising alum. The prese... |
|
|
Invention
|
Cpg-adjuvanted sars-cov-2 virus vaccine. Described herein are CpG-adjuvanted SARS-CoV-2 vaccines ... |
|
|
Invention
|
Alkyl chain modified imidazoquinoline tlr7/8 agonist compounds and uses thereof. Disclosed are al... |
|
|
Invention
|
Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (sars-cov-2). Pro... |
|
|
Invention
|
Immunogenic composition against severe acute respiratory syndrome coronavirus 2 (sars-cov-2). The... |
|
|
Invention
|
Active booster immunization against tetanus, diphtheria and pertussis.
The present disclosure re... |
|
|
Invention
|
Shingles vaccines comprising a tlr9 agonist.
The present disclosure relates to immunogenic compo... |
|
|
Invention
|
Active booster immunization against tetanus, diphtheria and pertussis. The present disclosure rel... |
|
|
Invention
|
Shingles vaccines comprising a tlr9 agonist. The present disclosure relates to immunogenic compos... |
|
|
Invention
|
Production of vaccines comprising inactivated sars-cov-2 viral particles.
Provided herein are me... |
|
|
Invention
|
Coronavirus vaccines comprising a tlr9 agonist.
The present disclosure relates to immunogenic co... |
|
|
Invention
|
Coronavirus vaccines comprising a tlr9 agonist. The present disclosure relates to immunogenic com... |
|
2020
|
G/S
|
Pharmaceutical and biological research, testing and product
development consultation; pharmaceut... |
|
|
G/S
|
Pharmaceutical preparations for the treatment, prevention, management, or control of hepatitis, v... |
|
|
G/S
|
Pharmaceutical preparations; vaccines; vaccine adjuvants. |
|
|
G/S
|
Pharmaceutical and biological research, testing and product development consultation; pharmaceuti... |
|
|
G/S
|
Pharmaceutical preparations for treating hepatitis, viruses and other infectious diseases, inflam... |
|
2019
|
Invention
|
Combination including a cpg-c type oligonucleotide and a pd-1 antagonist for treating breast canc... |
|
|
Invention
|
Combinations including a cpg-c type oligonucleotide and a histone deacetylase inhibitor for treat... |
|
2018
|
Invention
|
Cleavable conjugates of tlr7/8 agonist compounds, methods for preparation, and uses thereof. The ... |
|
|
Invention
|
Cleavable conjugates of tlr7/8 agonist compounds, methods for preparation, and uses thereof. Hcc]... |
|
|
Invention
|
Administration of polynucleotide toll-like receptor 9 agonists for treating cancer. The present d... |
|
|
Invention
|
Alkyl chain modified imidazoquinoline tlr7/8 agonist compounds and uses thereof. HH-imidazoquinol... |
|
|
Invention
|
Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer... |
|
|
Invention
|
Branched chimeric compounds, and methods of use thereof. The present disclosure relates to branch... |
|
|
Invention
|
Linear chimeric compounds and methods of use thereof. The present disclosure relates to branched ... |
|
|
G/S
|
Financial administration of patient reimbursement programs; financial administration of health re... |
|
|
Invention
|
Methods and compositions for eliciting an immune response against hepatitis b virus. The present ... |
|
2017
|
Invention
|
Intratumoral administration of particles containing a toll-like receptor 9 agonist and a tumor an... |
|
2016
|
G/S
|
Pharmaceutical preparations; Vaccines; Pharmaceutical preparations for treating allergies; Pharma... |
|
|
G/S
|
Vaccines; pharmaceutical preparations for the prevention of infectious diseases and chronic viral... |
|
|
Invention
|
Combination of an anti-il-10 antibody and a cpg-c type oligonucleotide for treating cancer. The p... |
|
|
Invention
|
Combination of a pd-1 antagonist and cpg-c type oligonucleotide for treating cancer. The present ... |
|
|
Invention
|
Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereof... |
|
2015
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of allergies, infectious diseases, c... |
|
2013
|
G/S
|
Human vaccines. |
|
|
G/S
|
Vaccines. |
|
|
G/S
|
Human vaccines. |
|
2006
|
G/S
|
Pharmaceutical preparations; vaccines. |
|
2005
|
G/S
|
Vaccines |
